Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer

Magnetic Resonance in Medicine

Volumn 74, Issue 6, 2015, Pages 1556-1563

  Xu, Xiang ^a,b   Chan, Kannie W Y ^a,b   Knutsson, Linda ^c   Artemov, Dmitri ^a   Xu, Jiadi ^a,b   Liu, Guanshu ^a,b   Kato, Yoshinori ^a,d   Lal, Bachchu ^e   Laterra, John ^e   McMahon, Michael T ^a,b   Van Zijl, Peter C M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c LUND UNIVERSITY   (Sweden)

^d HOSHI UNIVERSITY   (Japan)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

brain cancer; chemical exchange saturation transfer (CEST); D glucose; dynamic glucose enhanced MRI

Indexed keywords

BLOOD; BLOOD VESSELS; BRAIN; DISEASES; GLUCOSE; HEMODYNAMICS; MAMMALS; TUMORS;

BLOOD-BRAIN BARRIER; BRAIN CANCER; CHEMICAL EXCHANGE SATURATION TRANSFER; D-GLUCOSE; DYNAMIC CONTRAST ENHANCED MRIS (DCE); PERFUSION IMAGING; RELAXATION EFFECT; TUMOR BLOOD VOLUME;

MAGNETIC RESONANCE IMAGING;

GADOLINIUM PENTETATE; GLUCOSE; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; CANCER SIZE; CHEMICAL EXCHANGE SATURATION TRANSFER MAGNETIC RESONANCE IMAGING; CONTROLLED STUDY; DYNAMIC GLUCOSE ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC PERFUSION IMAGING; FEASIBILITY STUDY; FEMALE; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; IMAGE ENHANCEMENT; IMAGING AND DISPLAY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAXATION TIME; SIGNAL PROCESSING; U87 EGFRVIII CELL LINE; VULNERABLE POPULATION; ANIMAL; BLOOD FLOW VELOCITY; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SCID MOUSE; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GLUCOSE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; MICE, SCID; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84955191642     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25995     Document Type: Article

References (44)

1. O'Connor JP, Tofts PS, Miles KA, Parkes LM, Thompson G, Jackson A., Dynamic contrast-enhanced imaging techniques: CT and MRI. Br J Radiol 2011;84 Spec No 2: S112-S120.
2. Miles KA., Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 2003;76 Spec No 1: S36-S42.
3. Jackson A, Buckley DL, Parker GJM, editors. Dynamic contrast-enhanced magnetic resonance imaging in oncology. 2005.
4. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ., Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology 2015; 275: 772-782.
5. Chan KWY, McMahon MT, Kato Y, Liu G, Bulte JWM, Bhujwalla ZM, Artemov D, van Zijl PCM., Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med 2012; 68: 1764-1773.
6. Walker-Samuel S, Ramasawmy R, Torrealdea F, et al., In vivo imaging of glucose uptake and metabolism in tumors. Nat Med 2013; 19: 1067-1072.
7. Liepinsh E, Otting G., Proton exchange rates from amino acid side chains-implications for image contrast. Magn Reson Med 1996; 35: 30-42.
8. Ward KM, Aletras AH, Balaban RS., A new class of contrast agents for MRI based on proton Chemical Exchange Dependent Saturation Transfer (CEST). J Magn Reson 2000; 143: 79-87.
9. van Zijl PCM, Jones CK, Ren J, Malloy CR, Sherry AD., MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 2007; 104: 4359-4364.
10. Ling W, Regatte RR, Navon G, Jerschow A., Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A 2008; 105: 2266-2270.
11. Saar G, Zhang B, Ling W, Regatte RR, Navon G, Jerschow A., Assessment of GAG concentration changes in the intervertebral disc via CEST. NMR Biomed 2012; 25: 255-261.
12. McMahon MT, Gilad AA, DeLiso MA, Berman SM, Bulte JW, van Zijl PC., New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med 2008; 60: 803-812.
13. Nasrallah FA, Pages G, Kuchel PW, Golay X, Chuang K-H., Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI. J Cereb Blood Flow Metab 2013; 33: 1270-1278.
14. Rivlin M, Horev J, Tsarfaty I, Navon G., Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI. Sci Rep 2013; 3: 3045.
15. Rivlin M, Tsarfaty I, Navon G., Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3-O-Methyl-D-glucose. Magn Reson Med 2014; 72: 1375-1380.
16. Jin T, Mehrens H, Hendrich KS, Kim S-G., Mapping brain glucose uptake with chemical exchange-sensitive spin-lock magnetic resonance imaging. J Cereb Blood Flow Metab 2014; 34: 1402-1410.
17. Zu Z, Spear J, Li H, Xu J, Gore JC., Measurement of regional cerebral glucose uptake by magnetic resonance spin-lock imaging. Magn Reson Imaging 2014; 32: 1078-1084.
18. Yadav NN, Xu J, Bar-Shir A, Qin Q, Chan KWY, Grgac K, Li W, McMahon MT, van Zijl PCM., Natural D-glucose as a biodegradable MRI relaxation agent. Magn Reson Med 2014; 72: 823-828.
19. Gore JC, Brown MS, Mizumoto CT, Armitage IM., Influence of glycogen on water proton relaxation times. Magn Reson Med 1986; 3: 463-466.
20. Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J., EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Mol Cancer Ther 2009; 8: 1751-1760.
21. Zhu W, Kato Y, Artemov D., Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy. MAGMA 2014; 27: 161-170.
22. Donahue KM, Weisskoff RM, Chesler DA, Kwong KK, Bogdanov AA Jr, Mandeville JB, Rosen BR., Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996; 36: 858-867
23. Puri BK, Lewis HJ, Saeed N, Davey NJ., Volumetric change of the lateral ventricles in the human brain following glucose loading. Exp Physiol 1999; 84: 223-226.
24. Mueckler M., Facilitative glucose transporters. Eur J Biochem 1994; 219: 713-725.
25. Artemov D, Bhujwalla ZM, Pilatus U, Glickson JD., Two-compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy. NMR Biomed 1998; 11: 395-404.
26. Minakami S, Yoshikawa H., thermodynamic Considerations on Erythrocyte Glycolysis. Biochem Biophys Res Commun 1965; 18: 345-349.
27. Garrett RH, Grisham CM., Biochemistry 2010.
28. Van Zijl PC, Davis D, Eleff SM, Moonen CT, Parker RJ, Strong JM., Determination of cerebral glucose transport and metabolic kinetics by dynamic MR spectroscopy. Am J Physiol 1997; 273: E1216-E1227.
29. Gruetter R., Glycogen: the forgotten cerebral energy store. J Neurosci Res 2003; 74: 179-183.
30. Rothman DL, Novotny EJ, Shulman GI, Howseman AM, Petroff OA, Mason G, Nixon T, Hanstock CC, Prichard JW, Shulman RG., 1H-[13C] NMR measurements of [4-13C]glutamate turnover in human brain. Proc Natl Acad Sci U S A 1992; 89: 9603-9606.
31. Shulman RG, Rothman DL, Behar KL, Prichard JW., High resolution NMR studies of cerebral glucose metabolism in rats and humans Adv Exp Med Biol 1991; 291: 5-8.
32. Tofts PS, Brix G, Buckley DL, et al., Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
33. Tofts PS., Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101.
34. Gruetter R, Novotny EJ, Boulware SD, Rothman DL, Shulman RG., 1H NMR studies of glucose transport in the human brain. J Cereb Blood Flow Metab 1996; 16: 427-438.
35. Shestov AA, Emir UE, Kumar A, Henry PG, Seaquist ER, Oz G., Simultaneous measurement of glucose transport and utilization in the human brain. Am J Physiol Endocrinol Metab 2011; 301: E1040-E1049.
36. Zhou J, Payen J-F, Wilson DA, Traystman RJ, van Zijl PCM., Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085-1090.
37. Kim M, Gillen J, Landman BA, Zhou J, van Zijl PCM., Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 2009; 61: 1441-1450.
38. Sun PZ, Farrar CT, Sorensen AG., Correction for artifacts induced by B0 and B1 field inhomogeneities in pH-sensitive chemical exchange saturation transfer (CEST) imaging. Magn Reson Med 2007; 58: 1207-1215.
39. Reagan-Shaw S, Nihal M, Ahmad N., Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-661.
40. Lozner EL, Winkler AW, Taylor FH, Peters JP., The Intravenous Glucose Tolerance Test. J Clin Invest 1941; 20: 507-515.
41. Xu X, Jones CK, Yadav NN, et al., Dynamic imaging of D-glucose at 7T: first experiments in human brain. Proceedings of the ISMRM, 2015, Toronto, 1767.
42. Noguchi T, Yoshiura T, Hiwatashi A, et al., Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol 2008; 29: 688-693.
43. Zhou J, Wilson DA, Ulatowski JA, Traystman RJ, van Zijl PC, Two-compartment exchange model for perfusion quantification using arterial spin tagging. J Cereb Blood Flow Metab 2001; 21: 440-455.
44. Carruthers A., Facilitated diffusion of glucose. Physiol Rev 1990; 70: 1135-1176.